Table 2.
Variables | β-estimate | HR (95% CI) | P value | Score |
Age, years | 0.044 | 1.05 (1.02 to 1.07) | 0.001 | |
Elderly (age ≥80 years) | 0.706 | 2.03 (1.37 to 3.00) | <0.001 | 2 |
Female | 0.488 | 1.63 (1.08 to 2.46) | 0.020 | 2 |
Combination with antiplatelet agents | 0.392 | 1.48 (1.00 to 2.18) | 0.047 | 1 |
BMI, kg/m2 | −0.068 | 0.93 (0.88 to 0.99) | 0.020 | |
<18.5 | 1.062 | 2.89 (1.43 to 5.83) | 0.003 | 3 |
≥18.5, <25 | Ref | Ref | Ref | |
≥25 | −0.083 | 0.92 (0.61 to 1.38) | 0.690 | |
Systolic BP, mm Hg | −0.013 | 0.99 (0.98 to 1.00) | 0.042 | |
<90 | 1.540 | 4.66 (1.71 to 12.7) | 0.003 | 4 |
≥90, <140 | Ref | Ref | Ref | |
≥140 | −0.043 | 0.96 (0.58 to 1.58) | 0.865 | |
Diastolic BP, mm Hg | −0.010 | 0.99 (0.97 to 1.01) | 0.227 | |
<60 | 0.191 | 1.21 (0.73 to 2.02) | 0.465 | |
≥60, <90 | Ref | Ref | Ref | |
≥90 | −0.497 | 0.61 (0.22 to 1.66) | 0.332 | |
Type of atrial fibrillation | ||||
Paroxysmal | Ref | Ref | Ref | |
Persistent | −0.035 | 0.97 (0.52 to 1.79) | 0.912 | |
Permanent | 0.469 | 1.60 (1.07 to 2.40) | 0.023 | 2 |
No alcohol consumption | 0.500 | 1.65 (1.04 to 2.62) | 0.035 | 2 |
Diabetes mellitus | 0.416 | 1.52 (1.04 to 2.22) | 0.032 | 2 |
Heart failure | 0.556 | 1.74 (1.19 to 2.55) | 0.004 | 2 |
Prior stent implantation | 0.226 | 1.25 (0.84 to 1.88) | 0.273 | |
Prior CABG | −0.632 | 0.53 (0.25 to 1.14) | 0.106 | |
Creatinine clearance | −0.018 | 0.98 (0.97 to 0.99) | <0.001 | |
≥50 | Ref | Ref | Ref | |
≥30, <50 | 0.612 | 1.84 (1.23 to 2.78) | 0.003 | 2 |
<30 | 1.150 | 3.16 (1.67 to 5.96) | <0.001 | 3 |
BMI, body mass index; BP, blood pressure; CABG, coronary artery bypass grafting; NACE, net adverse clinical event.